← Eichor
Condition: Adverse Drug Event Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Adverse Drug Event

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Phase N/A · 1 location(s) · BioDelivery Sciences International · NCT03720613A Prognostic Model for Drug-induced Liver Injury in China
Phase N/A · 13 location(s) · Beijing Friendship Hospital · NCT05060289The CARDIOPROTECT Trial
Phase 2 · 1 location(s) · Beth Israel Deaconess Medical Center · NCT07654426Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events
NA · 3 location(s) · Ariel University · NCT06431308Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag
Phase 1 · 27 location(s) · AbbVie · NCT06896916Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
Phase 3 · 1 location(s) · University of Texas Southwestern Medical Center · NCT05358535Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
Phase N/A · 1 location(s) · Hubei Cancer Hospital · NCT07264985Chemokeyp: A Feasibility Study for Realtime Safety Data-Capture for Potential Serious Adverse Drug Events
Phase N/A · 1 location(s) · St Vincent's University Hospital, Ireland · NCT07592234Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
Phase 4 · 1 location(s) · University Hospitals Cleveland Medical Center · NCT06997198Pharmacogenetics of Antidepressant-Induced Disinhibition
Phase N/A · 1 location(s) · University of Calgary · NCT03953014Carotid Artery Corrected Flow Time and Inferior Vena Cava Collapsibility Index for Prediction of Hypotension After Induc
Phase N/A · 1 location(s) · Tanta University · NCT06814054Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06692504Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters.
Phase N/A · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06361784Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Venti
Phase 4 · 1 location(s) · Beijing Shijitan Hospital, Capital Medical University · NCT06575530Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk
NA · 1 location(s) · University Hospital, Montpellier · NCT06204549SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
Phase 2 · 3 location(s) · Queensland Centre for Gynaecological Cancer · NCT06278857Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery
NA · 1 location(s) · Mahidol University · NCT06216002Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome
Phase N/A · 11 location(s) · University Hospital, Lille · NCT04330118Effective Dosing of Burosumab in XLH
Phase N/A · 1 location(s) · University of Nottingham · NCT07183579The Efficacy of Vosevi in Treating DAA-experienced Patients
Phase N/A · 1 location(s) · The Third Affiliated Hospital of Guangzhou Medical Universit · NCT06180590Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation
Phase N/A · 2 location(s) · University of Manitoba · NCT06763081A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors
Phase 1 · 1 location(s) · Guangzhou FineImmune Biotechnology Co., LTD. · NCT06716619A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With J
Phase 3 · 33 location(s) · AbbVie · NCT06100744Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC)
NA · 4 location(s) · Murdoch Childrens Research Institute · NCT05667766Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
Phase N/A · 2 location(s) · University of Geneva, Switzerland · NCT05512169TDM for Optimized Outcome in Patients With mRCC.
Phase N/A · 1 location(s) · Niels Fristrup · NCT04659343Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery
NA · 1 location(s) · University of Ioannina · NCT07164300Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafe
Phase 4 · 1 location(s) · Instituto Mexicano del Seguro Social · NCT07678268Pharmacogenomics-Supported Psychotropic Prescribing Trial
NA · 2 location(s) · University of Manitoba · NCT06929533Atrial Fibrillation in Active Cancer Patients
Phase N/A · 1 location(s) · University Hospital, Caen · NCT04696081
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.